1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Bruker Corporation

Bruker Corporation

BRKRP
Bruker CorporationUS flagNASDAQ
445.25
USD
+0.51
- -
9.20BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
1,839
1,809
1,624
1,611
1,766
1,896
2,073
1,988
2,418
2,531
2,964
3,366
3,436
3,458
Operating Margin (%)
9.28
7.46
9.86
12.88
13.53
14.63
14.73
13.45
17.64
18.27
16.5
11.26
6.87
6.06
Depreciation Expense
61
60
53
54
64
65
76
80
89
89
115
184
220
228
Net Income, GAAP
80
57
102
154
79
180
197
158
277
297
427
113
-9
-12
Effective Tax Rate (%)
34.35
41.16
18.05
13.01
59.4
26.03
29.39
28.52
28.71
28.12
21.63
44.18
133.18
122.87
Profit Margin (%)
4.35
3.13
6.26
9.53
4.45
9.48
9.51
7.94
11.46
11.72
14.41
3.36
-0.25
-0.34
Working Capital
783
784
677
751
834
705
1,151
1,133
1,533
1,199
962
772
933
748
LT Debt
354
354
265
392
416
323
860
889
1,264
1,235
1,235
2,181
1,991
1,663
Total Equity
850
772
733
693
734
928
938
974
1,085
1,132
1,413
1,815
2,510
2,503
Return on Invested Capital (%)
9.56
6.6
11.88
16.72
8.4
16.32
13.43
9.83
13.32
13.12
14.08
5.93
-1.77
-1.18
Return on Capital (%)
9.58
6.23
10.63
14.05
6.22
13.2
11.33
7.27
10.5
9.75
12.61
3.3
-0.63
-0.63
Return on Common Equity (%)
14.28
9.01
14.34
18.66
8.59
17.55
16.57
11.76
18.06
16.53
20.09
4.78
-0.94
-1.52

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
24
52
8
LT Borrowings
1,984
1,852
1,663
LT Finance Leases
- -
139
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
152
152
152
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,351
2,212
2,104
Cash, Cash Equivalents & STI
293
299
133
Accounts Receivable, Net
551
545
543
Inventories
1,197
1,095
1,122
Total Current Liabilities
1,268
1,279
1,355
Payables & Accruals
184
441
269
ST Debt
24
52
8
Deferred Revenue
455
441
480

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.91%
21.45%
38.29%
Free Cash Flow
-2.97%
-21.82%
-89.78%
Net Income, GAAP
6.63%
-10.89%
-107.6%
Sales/Revenue/Turnover
8.05%
11.82%
2.08%
Total Cash Common Dividend
- -
-2.84%
-37.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
722
801
864
980
3,366
2025
801
797
860
977
3,436
2026
823
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Frank H. Laukien
Full Time Employees
11,085
Sector
Healthcare
Industry
Medical - Specialties
Address
40 Manning Road Billerica MA United States of America 01821
IPO Date
Sep 4, 2025
CIK
0001109354
Website
bruker.com
Similar Companies
AnteoTech Limited (ADO.AX)
i-SENS, Inc. (099190.KQ)
Zhende Medical Co., Ltd. (603301.SS)
Hass (450330.KQ)
Fielmann Group AG (FLMNY)
908 Devices Inc. (MASS)
Business
Bruker Corporation develops, manufactures, and distributes advanced scientific instrumentation and analytical and diagnostic tools, enabling clients to investigate biological and material structures at the microscopic, molecular, and cellular levels. The company functions through several key operational segments. Its Bruker BioSpin Group delivers life science instruments utilizing magnetic resonance technologies, including NMR and EPR spectrometers, along with advanced imaging systems like MRI, PET, SPECT, CT, Optical, and MPI modalities. The Bruker CALID Group concentrates on life science mass spectrometry and ion mobility spectrometry solutions, providing analytical and process analysis instruments. This segment also encompasses infrared and Raman molecular spectroscopy technologies and detection systems for chemical, biological, radiological, nuclear, and explosive substances. The Bruker Scientific Instruments (BSI) Nano Segment offers sophisticated X-ray instruments, atomic force microscopy, advanced fluorescence optical microscopy systems, analytical tools for electron microscopes, and X-ray metrology. It further provides defect-detection equipment for semiconductor process control, portable X-ray fluorescence spectrometry, spark optical emission spectroscopy platforms, and ChipCytometry products and services for spatial proteomics, multi-omics, and spatial genomics research. The Bruker Energy & Supercon Technologies (BEST) segment is engaged in superconducting and non-superconducting materials and devices, supporting applications in renewable energy, energy infrastructure, healthcare, and large-scale scientific research. Bruker's portfolio recently expanded through strategic acquisitions in spatial biology, molecular diagnostics, and lab automation platforms. Founded in 1960 by Günther Laukien and Emil Bruker in Karlsruhe, Germany, the company maintains its global headquarters in Billerica, Massachusetts.

Company News

APIChatGPT

  • seekingalpha.com

    Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript